Security file · CUSIP 761299AB2
TRAVERE THERAPEUTICS INC
TRAVERE THERAPEUTICS INC · held by 1 tracked manager in Q2 2025.
Tracked holders · Q2 2025
1
+0 vs Q4 2024
Aggregate reported value
$1.36M
sum of holders' reported positions
New holders this quarter
0
1 added · 0 trimmed
Holder return since filing
—
weighted by each holder's position share · since filing
Ownership · Q2 2025
| Manager | Weight | Shares | Δ shares | Entry | Return | Value | Activity | |
|---|---|---|---|---|---|---|---|---|
| 1 | Howard Marks - Oaktree Capital Managementfiled 13 Aug ET | 0.02% | 1.38M | +33.3% | — | — | $1.36M | Added |
Holder count
Aggregate reported value
Quarterly aggregation
| Quarter | Holders | Δ holders | Aggregate value | Total shares |
|---|---|---|---|---|
| Q2 2025 | 1 | +0 | $1.36M | 1.38M |
| Q4 2024 | 1 | — | $1.01M | 1.03M |